Kolexia
Kaderbhai Coureche Guillaume Oncologie médicale
Kaderbhai Coureche Guillaume
Oncologie médicale
Centre Georges-François Leclerc
Dijon, France
76 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Tumeurs du sein Carcinomes Tumeurs du sein triple-négatives Récidive tumorale locale Glioblastome Hémorragie des ganglions de la base

Collaborateurs

Voir plus
Ladoire Sylvain
Ladoire Sylvain
Centre Georges-François Leclerc, Dijon, France
Ghiringhelli Francois
Ghiringhelli Francois
Centre Georges-François Leclerc, Dijon, France
Favier Laure
Favier Laure
Centre Georges-François Leclerc, Dijon, France
Lagrange Aurelie
Lagrange Aurelie
Centre Georges-François Leclerc, Dijon, France

Industries

Voir plus
Ipsen
12 collaboration(s)
Dernière en 2023
Lilly
12 collaboration(s)
Dernière en 2023
AstraZeneca
8 collaboration(s)
Dernière en 2023
MSD
8 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Pan Tumor Nivolumab Rollover Study: Pan-Tumor Study for Long Term Follow-up of Cancer Survivors Who Have Participated in Trials Investigating Nivolumab
Essai Clinique (BMS)   14 février 2024
Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience.
Cancers   09 janvier 2024
255P Prognostic stratification capacity of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Breast cancer (Tokyo, Japan)   10 août 2023
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
Molecular cancer   29 juillet 2023
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.
International journal of molecular sciences   20 avril 2023
DURVALUNG: A Phase II Study of Durvalumab (MEDI 4736) Maintenance in Frail Limited Disease Small Cell Lung Cancer Patients After Thoracic Chemoradiotherapy (CRT)
Essai Clinique (AstraZeneca)   27 mars 2023
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.
Cancers   18 février 2023
Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results.
Breast (Edinburgh, Scotland)   04 février 2023
Pharmacokinetics and Pharmacodynamic of Alpelisib.
Clinical pharmacokinetics   12 janvier 2023